Literature DB >> 26976856

Tonsillectomy and Incidence of Oropharyngeal Cancers.

Anil K Chaturvedi1, Huan Song2, Phillip S Rosenberg3, Torbjorn Ramqvist4, William F Anderson3, Eva Munck-Wikland5, Weimin Ye2, Tina Dalianis4.   

Abstract

BACKGROUND: Rising incidence of oropharyngeal cancers in numerous countries since the 1970s has been attributed to increased oral human papillomavirus (HPV) exposure. However, the contribution of coincidental declines in the surgical removal of the tonsils (tonsillectomy) is unknown. We quantified the association of tonsillectomy with risk of tonsillar, other oropharyngeal, and other head and neck cancers and the contribution of declines in tonsillectomies to cancer incidence trends.
METHODS: We conducted a nation-wide cohort study in Sweden (1970-2009). Tonsillectomies (N = 225,718) were identified through national patient registers, which were linked with the cancer register. Cancer incidence in the tonsillectomy cohort was compared with Sweden's general population through standardized incidence ratios (SIR).
RESULTS: Tonsillectomies were associated with reduced risk of tonsil cancers [SIRs 1+ years post-tonsillectomy = 0.31; 95% confidence interval (CI), 0.08-0.79 and 5+ years post-tonsillectomy = 0.17; 95% CI, 0.02-0.62], but unrelated to other oropharyngeal or other head and neck cancers (SIRs 1+ years post-tonsillectomy = 1.61; 95% CI, 0.77-2.95 and 0.92; 95% CI, 0.64-1.27, respectively). The cumulative incidence of tonsillectomy declined significantly (40%-50%) during 1970-2009. However, tonsil cancer incidence significantly increased during 1970-2009 both without and with corrections for declines in tonsillectomies (relative risks per 5-year periods = 1.23, P < 0.001 and 1.20, P < 0.001, respectively).
CONCLUSIONS: The reduced tonsil cancer risk with tonsillectomy reflects the removal of most of the relevant tissue. The absence of associations with other head and neck cancers indicates that tonsillectomy may not impact carcinogenesis at other sites. IMPACT: The significant increases in oropharyngeal cancer incidence since the 1970s in Sweden appear independent of declines in tonsillectomies, reinforcing increased oral HPV exposure as the likely cause. Cancer Epidemiol Biomarkers Prev; 25(6); 944-50. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 26976856     DOI: 10.1158/1055-9965.EPI-15-0907

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

Review 1.  Current Role of Surgery in the Management of Oropharyngeal Cancer.

Authors:  Meghan T Turner; J Kenneth Byrd; Robert L Ferris
Journal:  J Oncol Pract       Date:  2016-11       Impact factor: 3.840

2.  Tonsillar swabs and sputum predict SLPI- and AnxA2 expression in tonsils: A prospective study on smoking dependent SLPI- and AnxA2-expression, and tonsillar HPV infection.

Authors:  Elgar Susanne Quabius; Alessa Heinrichs; André Kühnel; Martin Laudien; Florian Hoppe; Robert Mlynski; Petra Ambrosch; Markus Hoffmann
Journal:  Oncol Lett       Date:  2022-03-28       Impact factor: 2.967

Review 3.  Acupuncture Analgesia in Patients with Postoperative Neck Pain: A Protocol for Systematic Review and Meta-Analysis.

Authors:  Renming Liu; Songming Li; Yuhuan Liu; Min He; Jiazhen Cao; Mengmeng Sun; Changwei Duan; Tie Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-20       Impact factor: 2.650

4.  Evaluating the proposal of paediatric virology: An interview with Professor Tina Dalianis, Professor of Tumour Virology at Karolinska Institutet.

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2018-07-31       Impact factor: 2.447

5.  Childhood tonsillectomy alters the primary distribution of HPV-related oropharyngeal squamous cell carcinoma.

Authors:  Brannon Altenhofen; Todd A DeWees; Ji W Ahn; Nai C Yeat; Shreya Goddu; Ishita Chen; James S Lewis; Wade L Thorstad; Richard A Chole; Hiram A Gay
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.